NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.
- The FDA recommended advancement for a new drug application submitted by a company.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- FDA and Pfizer are seeking regulatory approval for their products.
- Nkarta is seeking protocol amendments for its clinical trials under the FDA.